Symbol="LYRA"
AssetType="Common Stock"
Name="Lyra TherapeuticsÂ Inc"
Description="Lyra Therapeutics, Inc., a clinical-stage therapeutic company, focuses on the development and commercialization of new integrated drug and delivery solutions for the localized treatment of patients with diseases of the ear, nose and throat. The company is headquartered in Watertown, Massachusetts."
CIK="1327273"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="SURGICAL & MEDICAL INSTRUMENTS & APPARATUS"
Address="480 ARSENAL STREET, WATERTOWN, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="163005000"
EBITDA="-60127000"
PERatio="None"
PEGRatio="None"
BookValue="1.99"
DividendPerShare="0"
DividendYield="0"
EPS="-1.46"
RevenuePerShareTTM="0.032"
ProfitMargin="0"
OperatingMarginTTM="-49.18"
ReturnOnAssetsTTM="-0.298"
ReturnOnEquityTTM="-0.581"
RevenueTTM="1238000"
GrossProfitTTM="-34234000"
DilutedEPSTTM="-1.46"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.128"
AnalystTargetPrice="12"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="53.54"
PriceToBookRatio="0.963"
EVToRevenue="1.536"
EVToEBITDA="0.357"
Beta="-0.0908"
num_52WeekHigh="6.48"
num_52WeekLow="1.86"
num_50DayMovingAverage="3.408"
num_200DayMovingAverage="2.936"
SharesOutstanding="49545600"
DividendDate="None"
ExDividendDate="None"
symbol="LYRA"
open="3.31"
high="3.38"
low="3.19"
price="3.30"
volume="33038.00"
latest_trading_day="2023-08-22"
previous_close="3.29"
change="0.01"
change_percent="0.3040%"
aroon_positive_momentum_days="73"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="73"
Volume_recent_avg="139368"
Change_recent_avg="0.01"
Delta_recent_avg="0.24"
Variance_recent_avg="0.12"
Change_ratio_recent_avg="0.04"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="73"
Aroon_momentum_negative="27"
image_negative_thumbnail_id_1="492"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0113.jpeg"
image_negative_thumbnail_id_2="515"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0090.jpeg"
image_neutral_thumbnail_id_1="574"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0025.jpeg"
image_neutral_thumbnail_id_2="536"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0063.jpeg"
image_positive_thumbnail_id_1="702"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0006.jpeg"
image_positive_thumbnail_id_2="637"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0071.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1191"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
